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The assembly of cytochrome c oxidase (CcO) in yeast mitochondria is dependent on a new 4 
assembly factor designated Coa2. Coa2 was identified from its ability to suppress the 5 
respiratory deficiency of coa1∆ and shy1∆ cells. Coa1 and Shy1 function at an early step in 6 
maturation of the Cox1 subunit of CcO. Coa2 functions downstream of Coa1 and the heme a3 7 
related function of Shy1. Cells lacking Coa2 exhibit a specific defect in CcO assembly and 8 
show a rapid degradation of newly synthesized Cox1. Rapid Cox1 proteolysis also occurs in 9 
shy1∆ cells; suggesting that in the absence of Coa2 or Shy1, Cox1 forms an unstable 10 
conformer. Overexpression of Cox5a and Cox6 or attenuation of the proteolytic activity of the 11 
m-AAA protease partially restores respiration in coa2∆ cells. The matrix localized Coa2 12 
protein may aid in the assembly of an early Cox1 intermediate containing the nuclear subunits 13 
Cox5a and Cox6. We propose that Coa2 functions at a Cox1 assembly checkpoint where 14 




 Cytochrome c oxidase (CcO) is the terminal enzyme of the energy transducing 2 
respiratory chain in mitochondria of eukaryotes. Eukaryotic CcO consists of 12-13 subunits, 3 
with three mitochondrial encoded subunits (Cox1-Cox3) forming the core enzyme embedded 4 
within the mitochondrial inner membrane (IM). The remaining nuclear encoded subunits pack 5 
on the periphery of the catalytic core (37). The core enzyme contains three copper atoms and 6 
two heme a cofactors (36).  7 
 The biogenesis of CcO, occurring within the IM, commences with the mitochondrial 8 
synthesis of the Cox1 subunit followed by the insertion of heme a and copper cofactors and 9 
the addition of the remaining subunits. The translation of Cox1 on mitoribosomes occurs in 10 
juxtaposition to the IM and is mediated in yeast by the IM-tethered translational activator 11 
Pet309 along with the IM-associated Mss51 (25, 26, 30, 32). The translational activators may 12 
recruit mitoribosomes and promote co-translational IM insertion together with the Oxa1 13 
translocase (9, 18).  14 
 Insights have also been gleaned on the assembly process of CcO through 15 
characterization of stalled intermediate complexes in human cells of patients with mutations 16 
in assembly factors.  One intermediate that accumulates in Leigh's syndrome patients with 17 
SURF1 mutations consists of Cox1, CoxIV and CoxVa (34, 38, 41). This intermediate fails to 18 
accumulate in patient cells with mutations in Cox10 or Cox15, two enzymes that function in 19 
heme a biosynthesis. Thus, the prediction is that heme a insertion occurs prior to the addition 20 
of CoxIV and CoxVa (corresponding to yeast Cox5a/b and Cox6) (1, 2). Two heme a 21 
moieties and a copper ion are buried inside a barrel within Cox1 (36). These cofactors may be 22 
inserted through an interface obstructed by the association of the Cox2 subunit. Consistent 23 
with this postulate is the fact that Cox2 associates downstream of the Cox1, Cox5a, Cox6 24 
complex (19).  25 
 Mss51, in conjunction with Cox14, has a post-translational function in yeast Cox1 26 
maturation (8, 30). Mss51 and Cox14 form a complex that interacts with Cox1 and regulates 27 
Cox1 translation/elongation. In cells lacking the yeast SURF1, shy1∆ cells, Cox1 translation is 28 
attenuated (8).  We recently reported that Coa1 functions in an early step of Cox1 assembly in 29 
yeast (31). Coa1 is part of the Mss51, Cox14, Cox1 complex and in addition binds to Shy1 30 
(27, 31). Coa1 appears to coordinate the transition of newly synthesized Cox1 from the Mss51 31 
 4 
complex to a later component involving Shy1 that likely functions in heme a3 insertion. We 1 
isolated a series of extragenic suppressors of coa1∆ cells. High copy MSS51, MDJ1 and 2 
COX10 suppress the respiratory defect of coa1∆ cells. In addition, we observed that 3 
respiration in both coa1∆ and shy1∆ cells is enhanced when MSS51 and COX10 are co-4 
expressed. The synergistic suppression is consistent with Mss51 and Cox10 affecting Cox1 5 
translation and heme a3 insertion suggesting that Coa1 links co-translational insertion and 6 
heme addition to Cox1.  7 
 A fourth extragenic suppressor of coa1∆ cells was found. High copy expression of the 8 
un-annotated yeast ORF, YPL189C-A, designated Coa2 for cytochrome oxidase assembly 2, 9 
is shown presently to effectively restore respiratory growth to coa1∆ and shy1∆ cells. We 10 
report that Coa2 functions in Cox1 maturation downstream from the Mss51 translational 11 
elongation step and at the heme a3 insertion step involving Shy1.  12 
 13 
MATERIALS AND METHODS 14 
 15 
Yeast strains and vectors. Yeast strains used in this study are described in Table I. The 16 
deletions strains were created by disruption using homologous recombination of KanMX4 or 17 
Candida albicans URA3. Proper integration was checked by PCR of the locus and reversion 18 
of the phenotype induced by the deletion was insured by complementation with a WT copy of 19 
the gene on a plasmid. Cells were cultured in either rich medium or synthetic complete (SC) 20 
medium lacking the appropriate nutrients for plasmid selection. The carbon source used was 21 
either 2% glucose, 2% glycerol-2% lactate or 2% raffinose. COA2 was cloned into YEp 22 
lac181 with 400 bp of its own promoter and terminator using BamHI and SalI. COA2 ORF 23 
was cloned into pRS416 under the control of the MET25 promoter and the CYC1 terminator 24 
(28) using BamHI and SalI. COX5a and COX6 were inserted in pRS426 and pRS423 under 25 
the control of their own promoter (600 and 430 bp respectively) and terminator (500 bp) by 26 
restriction with BamHI and XhoI. The vector containing Yta12 E614Q was a gift from Dr. 27 
Thomas Langer.  Sequencing was used to confirm cloning products in all created vectors.  28 
Yeast strains were transformed using lithium acetate.  29 
 30 
 5 
Mitochondria purification and assays. Intact mitochondria were isolated from yeast as 1 
described previously (13, 15). Total mitochondrial protein concentration was determined by 2 
Bradford assay (11). Cytochrome c oxidase activity was assessed by monitoring the oxidation 3 
of reduced cytochrome c and reaction rates were normalized to total mitochondrial protein 4 
(12). The oxygen consumption of the cells grown to stationary phase was determined on a 5 
5300A Biological Oxygen Monitor (Yellow Springs Instrument Co.). The linear response was 6 
considered in calculating the rate of oxygen consumption. Heme analysis was conducted on 7 
purified mitochondria (1-2 mg protein) extracted with 0.5 mL of acetone containing 2.5% HCl 8 
as described previously (31). The pH of the extract was adjusted to 4 by addition of 1 µL 9 
formic acid and titration of a KOH solution. The sample was clarified by centrifugation at 10 
13000 rpm for 5 min and 1 mL was injected onto a 3.9 x 300 mm C18 Bondclone column 11 
(Phenomex, USA).  12 
 13 
Hydrogen peroxide sensitivity, respiratory growth assay and arginine auxotrophy.  14 
Sensitivity of the strains and transformants to hydrogen peroxide was assessed as previously 15 
described (22). To test respiratory competence, the strains were grown overnight in selective 16 
medium containing 2% raffinose - 0.2% glucose, serially diluted and spotted on 2% glucose 17 
containing medium (control) and 2% glycerol-2% lactate rich (YPLG) or synthetic complete 18 
medium (SCLG).  The cox1∆::ARG8, COX1(1-512)::ARG8 strains and their derivatives were 19 
grown overnight in selective medium containing 2% glucose and 1x arginine (20 mg/mL Arg) 20 
or 0.2x Arg as indicated. The cultures were serially diluted and dropped onto synthetic 21 
complete medium 2% glucose containing no Arg or 1x Arg (control).  22 
 23 
In vivo mitochondrial protein translation assay. The cells were grown overnight in 24 
selective medium containing 2% raffinose and then re-inocculated in YP-2% raffinose to 25 
grow to an absorbance of 1 at 600 nm. The labeling and preparation of the samples for 12% 26 
SDS-PAGE or 15% SDS-PAGE (to visualize mp15) was as described in (7). The gel was 27 
dried and radiolabeled proteins were visualized by exposing autoradiographic films at -80°C.  28 
 29 
 6 
In vitro import into isolated mitochondria. In vitro import of Cox5a into isolated purified 1 
mitochondria was carried out as described (23) using Cox5a precursor protein labeled in a 2 
rabbit reticulocyte lysate (Promega, WI) with [35S]-Met. 3 
 4 
Blue native gel electrophoresis (BN-PAGE). BN-PAGE analysis was performed essentially 5 
as described (39) except that 1.5% digitonin was used. After incubation for 15 min on ice and 6 
centrifugation (20,000 g for 10 min at 2oC), supernatants were mixed with sample buffer (5% 7 
Coomassie brilliant blue G250, 0.5 M 6-aminocaproic acid, pH 7.0) and loaded on 4-13% or 8 
6-16% gradient polyacrylamide gel. Separated complexes were detected by immunoblotting 9 
on PVDF membrane or by autoradiography of dried gels.  10 
 11 
Immunoblotting. Protein samples were separated on 15% acrylamide gels and transferred to 12 
nitrocellulose. Proteins were visualized using ECL reagents with horseradish peroxidase-13 
conjugated secondary antibodies. Anti-Myc and HA antisera were purchased from Santa 14 
Cruz, anti-porin was from Molecular Probes and antisera to Cox1-Cox3 were from 15 
Mitosciences. Antiserum to Sod2 was provided by Dr. Val Culotta, and antisera to Cyb2 and 16 
Cyc1 were provided by Dr. Carla Koehler. Dr. Alex Tzagoloff provided antiserum to F1 ATP 17 




Coa2 is a multicopy suppressor of coa1∆ and shy1∆ respiratory growth defect. In a 22 
search for high copy suppressors of the respiratory growth defect of coa1∆ cells, we 23 
recovered MSS51, COX10 and MDJ1 (31). A fourth suppressor, which we designated COA2, 24 
was also identified (Fig. 1A).  Five plasmids recovered from the respiratory competent clones 25 
contained a DNA fragment encompassing YPL189c-a, an uncharacterized ORF that was 26 
identified by homology to an ORF in Ashbya gossypii (10, 20). Our identification of this gene 27 
as an extragenic suppressor and the respiratory deficiency of the deletion of YPL189c-a (10, 28 
20) imply that YPL189c-a is a functional gene. The complementation of the respiratory 29 
growth defect of coa1∆ cells by overexpression of COA2 is similar to that observed by 30 
overexpression of MSS51 (Fig. 1A).  Since Coa1 and Shy1 function at a related step in CcO 31 
 7 
assembly (31), we tested whether COA2 overexpression rescued the respiratory defect of 1 
shy1∆ cells. Coa2 overexpression was able to partially complement the respiratory growth 2 
defect of shy1∆ cells (Fig. 1B).  3 
 4 
coa2∆ cells are respiratory deficient with a CcO specific defect. The COA2 ORF was 5 
deleted by homologous recombination with a KanMX4 cassette in BY4741 and W303 strain 6 
backgrounds. The coa2∆ strains showed normal growth on glucose medium but were unable 7 
to propagate on respiratory medium containing glycerol and lactate as carbon sources (Fig. 8 
2A). Introduction of a centromeric plasmid expressing COA2 under the control of the MET25 9 
promoter and CYC1 terminator in the coa2∆ strains restored respiratory growth to WT level 10 
(Fig. 2B). Consistent with the growth defect observed on glycerol-lactate medium, oxygen 11 
consumption was strongly reduced in the coa2∆ strains compared to their isogenic WT (Fig. 12 
2C). Overall, these results confirm that Coa2 is necessary for respiration in S. cerevisiae as 13 
was shown by Kastenmayer and coworkers (Kastenmayer et al., 2006).  14 
Since Coa1 and Shy1 are part of the CcO assembly machinery, we assessed whether 15 
the absence of COA2 led to a CcO defect. CcO activity measured on purified mitochondria 16 
was diminished to about 10% of WT in the coa2∆ strains (Fig. 3A). Heme a, a cofactor 17 
exclusive to CcO, was undetectable in mitochondrial extracts of coa2∆ strains (Fig. 3B). The 18 
bc1 activity was reduced to 50-60% of WT and heme b levels were on average 58% of WT. 19 
Numerous CcO assembly mutants have reduced bc1 activity. Immunoblotting showed an 20 
absence of Cox1-Cox3 in mitochondria purified from the coa2∆ strain, while cytochrome c 21 
and Qcr7, a subunit of complex III, were present at WT levels (Fig. 3C).   Finally, CcO was 22 
undetectable by blue native PAGE (BN-PAGE) in the coa2∆ mitochondria (Fig. 3D). The 23 
absence of CcO caused complex III to be redistributed from the WT III2/IV2 and III2/IV 24 
supercomplexes into the dimeric form (III2) and the deletion of COA2 had no effect on 25 
complex V (Fig. 3D). Overall, these data argue for a specific CcO defect in coa2∆ cells.  26 
 27 
Coa2 is a mitochondrial matrix soluble protein partially associated with the IM. We 28 
chromosomally integrated three copies of the HA epitope at the 3’end of the COA2 ORF. The 29 
tag did not affect the function of Coa2 as judged by the WT growth on respiratory medium of 30 
 8 
the COA2-3HA strain (data not shown). Nycodenz gradient purified mitochondria isolated 1 
from the COA2-3HA strain showed a single band at ~17 kDa upon immunodetection with HA 2 
antiserum (Fig. 4A).  This apparent mass is higher than the expected 10.8 kDa, although the 3 
basic isoelectric point of Coa2 (10.6) may account for its aberrant migration on SDS-PAGE. 4 
Coa2 was detected predominantly in the soluble fraction of sonicated mitochondria like the 5 
soluble proteins Cyc1 and Sod2 (Fig. 4B). When the concentration of sodium chloride was 6 
increased in the sonication buffer, Cyc1 lost its membrane association as expected, whereas 7 
the fraction of Coa2 recovered in the pellet increased (Fig. 4B). This salt effect suggests that 8 
Coa2 may have a hydrophobic interaction with a mitochondrial membrane or with one of its 9 
proteins. This candidate interaction may involve a highly hydrophobic domain between 10 
residues 13 and 33 that was assigned to be a transmembrane helix by several topology 11 
prediction programs. In order to determine the sub-compartmentalization of Coa2, we treated 12 
intact or hypotonically-lysed mitochondria with proteinase K. The inner membrane space 13 
protein Cyc1 was degraded in mitoplasts, whereas Coa2 was protected similarly to the matrix 14 
protein Sod2 (Fig. 4C). However, Coa2 was degraded by proteinase K upon solubilization of 15 
mitochondria with Triton X100 (data not shown). Coa2, like Sod2, was retained in the 16 
insoluble fraction of mitoplasts, whereas it was liberated in the soluble fraction upon 17 
sonication of mitochondria (Fig. 4D). On the contrary, Ccs1, an IMS soluble protein, was 18 
mostly present in the soluble fraction of mitoplasts. Taken together, these results show that 19 
Coa2 is a soluble protein in the mitochondrial matrix and that Coa2 may have an interaction 20 
with an IM anchored protein or the inner membrane itself.  21 
 22 
The absence of COA2 leads to low level of newly synthesized Cox1. In vivo labeling of 23 
mitochondrial translation products revealed that very limited amounts of Cox1 were detected 24 
in coa2∆ cells in both W303 and BY4741 backgrounds. Cox2, Cox3 and Var1 were translated 25 
at WT levels while Cob (Cyt b) translation was slightly increased (Fig. 5A and Supplementary 26 
Fig. 1). During the 60 min chase, the levels of Var1 and Cyt b remained stable, whereas Cox2 27 
and Cox3 diminished markedly in coa2∆ cells, a phenomenon consistent with a CcO 28 
assembly defect.  Low abundance of Cox1 during the pulse phase of in vivo mitochondrial 29 
translation experiments has been reported for most CcO mutants (8). This has been proposed 30 
to result from the accumulation of a Mss51:Cox14:Cox1 complex which titrates Mss51 out of 31 
 9 
its Cox1 translational activator role (8). The synthesis of Cox1 can be restored in certain CcO 1 
mutants when Mss51 is overexpressed, when COX14 is deleted (8) or when COA1 is deleted 2 
(31).  Deletion of COX14 or COA1 in coa2∆ cells restored WT levels of newly synthesized 3 
Cox1, whereas overexpression of Mss51 only partially returned Cox1 (Fig. 5B). However, 4 
none of these strains recovered respiratory growth (data not shown).  5 
Recently, Barrientos and coworkers showed that attenuation of Mss51 levels or 6 
titration of Mss51 out of its Cox1 translational activator role leads to the synthesis of mp15, a 7 
truncated translation product of COX1 mRNA in the W303 background (40). Mp15 was 8 
apparent in cox5a∆ cells, but its abundance was lower in coa2∆ cells (Fig. 5C). Consistent 9 
with reported data (40), mp15 synthesis was abrogated when cox5a∆ or coa2∆ cells were 10 
treated with chloramphenicol prior to labeling and the synthesis of some Cox1 was restored 11 
(Fig. 5C). The low abundance of mp15 in coa2∆ cells suggests that Mss51 is still able to 12 
fulfill its translation functions in the absence of COA2.  13 
 14 
Cox1 is translated but rapidly degraded in coa2∆ cells. To evaluate the status of translation 15 
at the COX1 locus in coa2∆ cells, we used Arg8 reporter strains constructed by Fox and 16 
coworkers (30). Arg8 is encoded by a nuclear gene and is imported to the mitochondrial 17 
matrix where it participates in the biosynthesis of arginine. These reporter strains constructed 18 
in an arg8∆ background, contain the ARG8 gene in place of COX1 ORF (cox1∆::ARG8) or 19 
fused at the 3' end of the 512 codon intronless form of the COX1 coding sequence (COX1(1-20 
512)::ARG8) (30). The growth of these strains in medium lacking arginine is indicative of 21 
translation of COX1(1-512)::ARG8 mRNA. Deletion of COA2 in these two strains did not 22 
produce an arginine auxotrophy, implying that translation was occurring at the COX1 locus 23 
(Fig. 6A). As expected, the COX1(1-512)::ARG8 strain was unable to respire when COA2 was 24 
deleted (Fig. 6A). To ascertain that the arginine prototrophy of the cox1∆::ARG8 and 25 
COX1(1-512)::ARG8 strains lacking COA2 was not sustained by only low amounts of Arg8, 26 
we performed in vivo mitochondrial translation assays in these strains. The level of mature 27 
Arg8 detected in the cox1∆::ARG8 strain was comparable whether COA2 was present or not 28 
(Fig. 6B). In the COX1(1-512)::ARG8 strain, a band corresponding to the unprocessed fusion 29 
was detected during the pulse phase of the reaction independently of the presence of COA2 30 
(Fig. 6C). The processing of this band into Cox1 and Arg8 during the chase was variable 31 
 10 
between experiments. However, the level of total Arg8 (processed Arg8 and Cox1-Arg8 1 
fusion) was comparable between the strains containing or not COA2, whereas the amount of 2 
processed Cox1 at the end of the chase was consistently greatly reduced in the absence of 3 
COA2. The experiments with the Arg8 reporter strains show that efficient translation occurs at 4 
the COX1 locus even when the COA2 gene is deleted.  5 
 We previously reported that Mss51 is distributed into 2 complexes when analyzed by 6 
BN-PAGE (31). The largest of this complex (complex A) has been postulated to contain 7 
Cox14, Coa1 and newly synthesized Cox1 based on the observations that this complex is 8 
disrupted upon deletion of COX14 and is stabilized in shy1∆ cells (31).  Complex A was 9 
resolved into two different complexes A1 and A2 when a gel with a 4-13% gradient was used 10 
(Fig. 6D).  These two complexes were abrogated upon deletion of PET309, a COX1 11 
translational activator (Fig. 6D), supporting the assumption that newly synthesized Cox1 is 12 
required for the formation of complexes A1 and A2.  These complexes were not significantly 13 
perturbed by the deletion of COA2, suggesting that newly synthesized Cox1 is present in this 14 
strain. Altogether, the data strongly suggest that the CcO deficiency in coa2∆ cells is not a 15 
result of a translation defect of Cox1.  16 
The m-AAA protease composed of Yta10-Yta12 is known to degrade non-assembled 17 
mitochondrially encoded proteins within the IM (4). Additionally, the m-AAA protease is 18 
essential for mitoribosome assembly through processing of MrpL32 (35). To evaluate whether 19 
the m-AAA protease was responsible for the low level of newly synthesized Cox1 in coa2∆ 20 
cells, we used a mutant m-AAA containing a E614Q substitution in Yta12 that attenuates its 21 
proteolytic activity yet maintains its processing function (3, 35). Respiratory growth was 22 
partially restored in coa2∆ cells when YTA12 was deleted and replaced with the Yta12 E614Q 23 
allele (Fig. 6E). Therefore, rapid degradation of Cox1 contributes to the CcO deficiency in 24 
coa2∆ cells.  25 
 26 
Coa2 acts downstream of Shy1, Coa1 and Cox14 in CcO assembly pathway. Deletion of 27 
certain CcO assembly factors, such as Cox11 and Sco1, render yeast cell sensitive to 28 
hydrogen peroxide (6), a phenotype generated by a pro-oxidant heme a3-containing Cox1 29 
assembly intermediate (22).  We found that coa2∆ cells are also sensitive to hydrogen 30 
peroxide in a Cox1-dependent way, as the cox1∆::ARG8 strain did not exhibit sensitivity in 31 
 11 
the absence of COA2 (Fig. 7A). Thus, despite low levels of Cox1 observed in the [35S] 1 
translation assay in coa2∆ cells, sufficient Cox1 was present to cause the peroxide sensitivity. 2 
This highlights the sensitivity of the hydrogen peroxide assay. We showed previously that 3 
peroxide sensitivity was dependent on heme a3 insertion into Cox1 (22). We took advantage 4 
of this phenotype to define the step in CcO assembly at which Coa2 is involved. Deletion of 5 
COA1, SHY1 or COX14 in coa2∆ cells abrogated the peroxide sensitivity (Fig. 7B), despite 6 
the elevated levels of newly synthesized Cox1 detected in coa2∆,coa1∆ and coa2∆,cox14∆ 7 
cells (Fig. 5B). Deletion of COA1 or COX14 must preclude heme a3 insertion as is the case 8 
with SHY1 disruption. These data together with the fact that overexpression of Coa2 can 9 
suppress coa1∆ and shy1∆ cells strongly support a role for Coa2 downstream of Coa1, Cox14 10 
and Shy1 in the assembly pathway of CcO.  11 
 12 
The respiratory defect of coa2∆ cells is suppressed by overexpression of Cox5a and 13 
Cox6. Cox1 occupies a central position in the mature CcO structure (37). We reasoned that 14 
the rapid degradation of Cox1 in coa2∆ cells likely occurs at an early stage in CcO assembly. 15 
In humans, CoxIV and CoxVa (yeast Cox5a and Cox6) associate with Cox1 as the first 16 
subassembly intermediate (29, 38) and these subunits are in close contact with Cox1 in the 17 
bovine CcO (Fig. 8A). We addressed whether Cox5a and Cox6 have a significant effect on 18 
Cox1 stability at early stages of CcO assembly. We performed in vivo mitochondrial 19 
translation experiments in strains carrying deletion of different CcO subunits, early assembled 20 
subunits like Cox5a and Cox6 and subunits assembled at a latter stage like Cox7 and Cox12. 21 
Only minimal levels of Cox1 were detected in cox5a∆ and cox6∆ cells, whereas cox7∆ and 22 
cox12∆ cells showed WT levels of Cox1 during the pulse of the reaction (Fig. 8B). This result 23 
prompted us to overexpress Cox5a and Cox6 in coa2∆ cells. The two genes, when 24 
overexpressed individually, showed suppression of coa2∆ respiratory defect at 37°C (Fig. 25 
8C). However, Cox5a and Cox6 had to be overexpressed together to produce significant 26 
growth of coa2∆ cells at 30°C (Fig. 8C). Coa2 is probably not required for Cox5a stability 27 
per se, since the same residual level of Cox5a was detected in coa2∆ or in cox19∆ cells (Fig. 28 
8D). Cox19 is another CcO assembly factor. Coa2 may therefore aid in complex formation 29 
between Cox5a and newly synthesized Cox1.  30 
 12 
 Genomically tagged Coa2 migrated on BN-PAGE as a single complex whose mass 1 
was approximately 100 kDa (Fig. 8E). This is in contrast to the predicted mass of 27 kDa for 2 
Coa2-13Myc. The observed Coa2 complex is smaller that any of the Cox5a containing 3 
complexes described recently (27) suggesting that Coa2 may not form a stable complex with 4 
Cox5a. Immunoprecipitation experiments between Coa2 and Cox5a failed to show an 5 
interaction between the two proteins (data not shown). In addition, import of radiolabeled 6 
Cox5a into purified mitochondria from WT cells and cells containing Coa2-13Myc showed 7 
the same mass complexes (Supplemental Fig. 2). A mass shift was shown to occur in the 8 
import of radiolabeled Cox5a in mitochondria containing an epitope-tagged Shy1 relative to 9 
mitochondria with an untagged Shy1 (27). Due to the  low Met and Cys content of Coa2, we 10 
engineered a C-terminal extension with 6 methionine residues. However, attempts to 11 
radiolabel Coa2 in vitro with 35S were unsuccessful, precluding experiments to assess the 12 
association of Coa2 in transient complexes upon in vitro import.  The 100 kDa Coa2 complex 13 
does not appear to contain Cox1, since this complex on BN-PAGE was apparent in pet309∆ 14 
cells in which Cox1 is not translated (data not shown). We failed to detect an interaction 15 
between Coa2 and newly synthesized Cox1 when Coa2 was immunoprecipitated from 16 
radiolabeled mitochondria (data not shown). However, not all IM complexes are stably 17 
maintained under BN-PAGE conditions (14). 18 
 19 
COA2 and MSS51 have non-redundant complementary functions. As in coa2∆ cells, 20 
Cox1 synthesis is also unusually low in cox5a∆ cells. In order to test whether the low level of 21 
Cox1 detected in cox5a∆ (Fig. 8A) was a result of lack of translation or rapid degradation, we 22 
disrupted COX5a in the COX1(1-512)::ARG8 strain. This strain showed a partial arginine 23 
auxotrophy which was reversed by overexpression of MSS51 or COA2 (Fig. 9A). Consistent 24 
with the Cox1 translation block model (8), overexpression of MSS51 in a cox5a∆ strain 25 
partially returned the level of newly synthesized Cox1 while COA2 overexpression did not 26 
(Fig. 9B). These results suggest that MSS51 probably increases translation of the Cox1-Arg8 27 
fusion to rescue the arginine auxotrophy of the COX1(1-512)::ARG8 cox5a∆ strain, whereas 28 
COA2 suppression may arise in a post-translational step through stabilization of the translated 29 
Cox1-Arg8. The low intensity of this band by in vivo mitochondrial translation assay in the 30 
COX1(1-512)::ARG8 cox5a∆ strain prevented us from directly testing this hypothesis.  31 
 13 
We subsequently assayed the peroxide sensitivity of the cox5a∆ strain to assess heme 1 
a3:Cox1 levels. Cells lacking Cox5a were not sensitive unless MSS51 or COA2 were 2 
overexpressed (Fig. 9C). The coexpression of the two proteins further increased the peroxide 3 
sensitivity (Fig. 9C), arguing for non-redundant functions of MSS51 and COA2. High levels 4 
of Mss51 and Coa2 appear to enhance Cox1 levels, via translational and post-translational 5 
effects respectively.  6 
A synergistic effect of MSS51 and COA2 was also found in the suppression of the 7 
respiratory defect of coa1∆, a strain that has impaired CcO assembly due to a post-8 
translational defect (Fig. 10A). Similarly, co-overexpression of MSS51 and COA2 improved 9 
the growth of a shy1∆ strain (Fig. 10B). Taken together, these results suggest that Coa2 is 10 
involved in Cox1 maturation at a post-translational step after the heme a3 insertion mediated 11 
by Shy1. The respiratory defect of a shy1∆ strain was recently shown to be partially 12 
suppressed by overexpression of Cox5a and Cox6 (16). We did not observed any synergism in 13 
the suppression of a shy1∆ strain when these 2 subunits were overexpressed in combination 14 
with Coa2 (data not shown) suggesting that Coa2, Cox5a and Cox6 function at a related step 15 




Coa2 is a 68 residue mitochondrial protein shown to be required for respiration and 20 
having a specific role in CcO assembly. The most striking aspect of the CcO deficiency of 21 
coa2∆ cells is a rapid degradation of newly synthesized Cox1. Only limited quantity of newly 22 
synthesized Cox1 is observed with in vivo mitochondrial translation and this limitation results 23 
from rapid degradation rather than impaired synthesis. Two lines of evidence support this 24 
conclusion. First, deletion of COA2 in a COX1(1-512)::ARG8 fusion strain resulted in normal 25 
growth on medium lacking arginine, whereas deletion of COX5a in the same background 26 
induced an Arg auxotrophy partially due to restricted translation. Second, respiration was 27 
partially recovered in coa2∆ cells by diminishing the activity of the m-AAA protease, a 28 
complex which has been shown to degrade misfolded inner membrane proteins (5).  29 
 30 
 14 
COX1 translation is impaired in many CcO assembly mutants due to the titration of 1 
Mss51 into a post-translational complex, preventing its function as a translational activator of 2 
COX1 (8). This COX1 translation block is unlikely or at least limited in coa2∆ cells, since 3 
Arg8 is translated essentially normally in COX1(1-512)::ARG8 coa2∆ cells.  The attenuation 4 
of Mss51 as a translational activator is also known to result in synthesis of a truncated Cox1 5 
translation product called mp15 (40). Whereas mp15 synthesis occurs in cox5a∆ cells, only 6 
limited synthesis of mp15 occurs in coa2∆ cells. 7 
A translation block of Cox1 likely exists in the absence of COX5a as shown by the 8 
rescue of the Arg auxotrophy of COX1(1-512)::ARG8 cox5a∆ cells by MSS51 overexpression 9 
and by the recovery of some level of newly synthesized Cox1 in a cox5a∆ strain 10 
overexpressing MSS51. The translation block occurring in most CcO mutants can be obviated 11 
in cells lacking Coa1 or Cox14. The deletion of COX14 leads to a marked enhancement in 12 
Cox1 synthesis, but the newly synthesized Cox1 does not progress to assembled CcO (8). 13 
Deletion of either COA1 or COX14 in coa2∆ cells leads to a pronounced increase in newly 14 
synthesized Cox1 in an in vivo mitochondrial translation assay. The accumulated Cox1 must 15 
be in an environment where it is protected from the protease responsible of its rapid 16 
degradation in coa2∆ cells. Cox14 and Coa1 are essential to coordinate Mss51's post-17 
translational function leading to cofactor insertion in Cox1 (31). Therefore, disruption of 18 
COX14 or COA1 likely prevents newly synthesized Cox1 from joining the assembly chain. 19 
Indeed the reversal of the peroxide sensitivity of coa2∆ cells by deletion of COX14 or COA1, 20 
even though it increases greatly the amount of newly synthesized Cox1 visible in the 21 
translation assay, suggests that this Cox1 is devoid of heme a3. Shy1 has been shown to be 22 
important for heme a3 insertion in Rhodobacter (33), and the fact that deletion of SHY1 in 23 
coa2∆ cells also reverses the peroxide sensitivity supports this point. 24 
At what step in CcO assembly is Coa2 important? Three lines of evidence suggest that 25 
Coa2 functions downstream of Coa1 and the heme a3 related function of Shy1. First, the 26 
Coa1:Mss51:Cox14:Cox1 complex is unaffected in coa2∆ cells. Second, Cox1 can acquire 27 
heme a3 in the absence of COA2, a step that is abrogated by the deletion of COA1 and SHY1 28 
as shown by the reversal of the peroxide sensitivity of coa2∆ cells. Third, overexpression of 29 
COA2 suppresses the respiratory phenotype of coa1∆ and shy1∆ cells. These results strongly 30 
point to Coa2 acting downstream of these two assembly factors. Although Shy1 appears to be 31 
 15 
important in the heme a3 insertion step, Shy1 stays associated with CcO until the 1 
supercomplex stage (27). It remains unclear whether Shy1 has any function downstream of 2 
the proposed heme a3 assembly step.   3 
Proteolytic degradation of Cox1 may be a protective response to the assembly of the 4 
pro-oxidant heme a3:Cox1 intermediate. The enhanced activity in coa2∆ cells may suggest 5 
that Coa2 functions at a Cox1 assembly checkpoint that couples the progression of Cox1 6 
assembly and degradation of stalled heme a3:Cox1 intermediates. In the absence of heme a3 7 
insertion, Cox1 assembly intermediates, e.g. in cox14∆ cells, are not deleterious and perhaps 8 
not a priority for the cell to remove proteolytically.   9 
We show that COX5a and COX6 partially suppress the respiratory defect of coa2∆, 10 
arguing for Coa2 functioning upstream or proximate to these two subunits joining Cox1. 11 
COX5a and COX6 were recently shown to partially suppress the respiratory defect of shy1∆ 12 
cells (16). In this case, the authors suggested that Cox5a and Cox6 protect newly synthesized 13 
Cox1 from proteolytic degradation. Therefore, it is possible that at least part of the decrease in 14 
the amount of newly synthesized Cox1 observed in shy1∆ actually results from rapid 15 
degradation of Cox1 and not entirely from a translation block. This argument is supported by 16 
the observation that a COX1(1-512)::ARG8 shy1∆ strain has no growth defect on medium 17 
lacking Arg (30) and that normal level of Arg8 are present in the COX1(1-512)::ARG8 strain 18 
in the absence of SHY1 (30). Therefore, the same rapid Cox1 proteolysis may occur in shy1∆ 19 
as well as in coa2∆ cells suggesting that in the absence of these factors Cox1 forms an 20 
unstable conformer. Given the close packing of Cox5a against Cox1, Cox5a may have a 21 
stabilizing effect on newly synthesized Cox1.  22 
An early step in Cox1 maturation is formation of the Cox1:Cox5a:Cox6 subassembly 23 
complex (34, 38). Cox5a packs against transmembrane helices 11 and 12 in Cox1 and 24 
together with Cox6 packs onto the matrix face of the Cox1 helical barrel stabilizing loops 25 
connecting the 12 membrane helices. This complex accumulates in mammalian cells with 26 
mutations in SURF1 (Shy1) (34, 38). This assembly intermediate likely contains heme a, 27 
since mutant Cox10 or Cox15 fibroblast lines fail to form this intermediate (1, 2). Heme a is 28 
axially coordinated by histidyl residues from Cox1 helices 2 and 10 and its farnesyl tail packs 29 
between helices 1, 11 and 12 (36). Thus, heme a insertion may assist in organizing the Cox1 30 
helices creating the Cox5a interface.  31 
 16 
It is conceivable that heme a produced by Cox10/Cox15 and inserted into newly 1 
synthesized Cox1 creates a Cox1 conformer competent for Cox5a,Cox6 binding. The heme 2 
a3:CuB site may be formed in a second step mediated by Shy1 and Cox11. These two steps 3 
may occur concurrently rather than sequentially. In support of concurrent steps, a 350 kDa 4 
Cox1 assembly intermediate contains both Shy1 and Cox5a, although distinct 250 kDa 5 
complexes exist with either Shy1 or Cox5a (27). Coa2 may have a chaperone activity in 6 
promoting Cox5a/Cox6 association with Cox1, but appears independent of the Shy1 step. The 7 
inability to efficiently form the Cox1:Cox5a:Cox6 intermediate in coa2∆ cells could expose 8 
Cox1 to rapid proteolysis. In shy1∆ cells the unstable Cox1 intermediate may lack heme a3. 9 
Coa2 likely suppress shy1∆ respiratory defect via a post-translational effect on Cox1. We did 10 
not detect any enhancement of the suppression of shy1∆ by Coa2 when Cox5a and Cox6 were 11 
also overexpressed. Therefore, it is probable that Coa2 suppresses the respiratory defect of 12 
shy1∆ cells by a similar mechanism as Cox5a and Cox6 which was proposed to be due to 13 
increasing the stability of newly synthesized Cox1 (16). Such a role of Coa2 would also 14 
explain the H2O2 sensitivity of a cox5a∆ strain overexpressing Coa2. Even though we failed to 15 
detect any stable interaction between Coa2 and Cox1 or Cox5a, a transient interaction may 16 
occur. Coa2 showed a salt-dependent association with the membrane fraction consistent with 17 
a hydrophobic interaction that could involve one of these protein. Future studies will focus on 18 
the components in the Coa2 complex.  19 
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Figure Legends 13 
 14 
Fig. 1.  Overexpression of COA2 can suppress the respiratory growth defect of coa1∆ 15 
and shy1∆ cells.  A) coa1∆ cells (BY4743 background) transformed with episomal vectors 16 
expressing MSS51, MDJ1,COX10 or COA2 were grown in SC-2% raffinose, serially diluted 17 
and spotted on SC 2% glycerol-2% lactate (SCLG) or 2% glucose. The plates were incubated 18 
at 30°C for 2 days (glucose) or 7 days (SCLG). B) shy1∆ cells (W303 background) 19 
transformed with an episomal vector expressing COA2 or an empty vector were grown as in 20 
A) and spotted on YP 2% glycerol-2% lactate (YPLG) or 2% glucose. The plates were 21 
incubated at 30°C for 2 days (glucose) or 4 days (YPLG).  22 
 23 
Fig. 2.  coa2∆ cells are respiratory deficient.  A) coa2∆ cells and the isogenic WT (BY4741 24 
or W303) were grown in liquid YPD then serially diluted and spotted on YP 2% glycerol-2% 25 
lactate (YPLG) or 2% glucose plates (YPD). The plates were incubated at 30°C for 2 days 26 
(YPD) or 4 days (YPLG). B) coa2∆, the isogenic WT and coa2∆ cells transformed with a 27 
centromeric vector expressing COA2 ORF under the control of the MET25 promoter and the 28 
CYC1 terminator were grown in SC-2% glucose, serially diluted and spotted on YPD or SC-29 
2% glycerol-2% lactate (SCLG). The plates were incubated as in A). C) coa2∆ cells and the 30 
 22 
WT were grown in liquid YPD at 30oC and oxygen consumption (% O2/sec/OD600) was 1 
measured. The data represent the average of 4 independent experiments. 2 
 3 
Fig. 3. Deletion of COA2 results in a CcO specific defect.  A) coa2∆ cells and the isogenic 4 
WT were grown in YP-2% raffinose, mitochondria were purified and assayed for CcO 5 
activity (∆OD550/min/10 µg protein). The data represent the average of 3 independent 6 
experiments. B) Heme was extracted from mitochondria (2 mg protein) purified from coa2∆ 7 
or W303 cells and separated by reverse phase HPLC.  The peaks corresponding to heme b (B) 8 
and heme a (A) and protoporphyrin (P) are shown. C) Immunoblot of mitochondria (30 µg 9 
protein) from coa2∆ cells or from wild-type W303. D) Mitochondria (200 µg protein) isolated 10 
from either wild-type (WT) or coa2∆ strains were solubilized in buffer containing 1.5% 11 
digitonin. Lysates were loaded onto a continuous 4-13% gradient gel and protein complexes 12 
were separated by BN-PAGE. The distribution of respiratory complexes was analyzed by 13 
immunoblotting with antisera against Cyt1, Cox2 and F1-subunit. 14 
 15 
Fig.4. Coa2 is a soluble matrix protein partially associated with the inner-membrane. A) 16 
Immunoblot of mitochondria and post-mitochondrial fraction (PMF) purified from the COA2-17 
3HA strain. Pgk1 is a cytosolic marker and Por1 is a mitochondrial outer-membrane (OM) 18 
protein.  B) Purified mitochondria from the COA2-3HA strain were sonicated in Hepes 20 19 
mM pH 7.4 and the indicated concentration of NaCl. The soluble and insoluble fractions were 20 
separated by centrifugation at 100,000 g for 1 h and analyzed by immunoblot. Cyt1 is an 21 
integral inner-membrane (IM) protein, Cyc1 is associated with the IM and Sod2 is a matrix 22 
soluble protein. C) Purified mitochondria from the COA2-3HA strain were incubated in 23 
Hepes 20 mM pH 7.4 with 1.2 M Sorbitol (intact) or without it (hypotonic) for 30 min on ice, 24 
digested on ice for 40 min with the indicated concentration of proteinase K (PK) (µg/mL) and 25 
analyzed by immunoblotting. D) Purified mitochondria from the COA2-3HA strain were 26 
sonicated or incubated in Hepes 20 mM pH 7.4 with 1.2 M Sorbitol (intact) or without it 27 
(hypotonic) for 30 min on ice. The soluble (S) and insoluble fractions (P) were separated by 28 




Fig. 5. The absence of COA2 leads to low level of newly synthesized Cox1. A) In vivo 1 
labeling of mitochondrial translation products. coa2∆ and WT cells were pulsed for 5 and 15 2 
min with [35S]-methionine.  After 15 min, 20 mM of cold methionine (Met) was added and 3 
the reaction was chased for 20 and 60 min at 30°C. The samples were run on 12% SDS-4 
PAGE, the gel was dried and exposed to autoradiographic film. B) Cells were labeled for 8 5 
and 20 min with [35S]-Met at 30°C. The samples were analyzed as in A). C) W303 coa2∆ or 6 
cox5a∆ cells were treated (+) or not (-) for 3 h with 2 mg/mL chloramphenicol (CAP) and 7 
then pulsed for 20 min with [35S]-Met. The samples were run on 15% SDS-PAGE, the gel 8 
was dried and exposed to autoradiographic film. 9 
 10 
Fig. 6. Cox1 is translated in the absence of COA2. A) COA2 was deleted in arg8∆  strains 11 
in which ARG8 replaces the COX1 codons (cox1∆::ARG8) or ARG8 is fused to 512 codons of 12 
COX1 (COX1(1-512)::ARG8).  The strains were grown in SC-2% glucose containing 0.2x 13 
Arg (4 mg/L), serially diluted and spotted on YPD, SC-2% glucose with or without 1x Arg 14 
and YPLG. The plates were incubated at 30°C for 2 days (glucose plates) or 4 days (YPLG). 15 
The arg4∆ strain is shown as a control. B) In vivo labeling of mitochondrial translation 16 
products of the cox1∆::ARG8 strain with or without the COA2 gene. The cells were treated as 17 
in Fig.5A. The additional band is the mature Arg8. C) The COX1(1-512)::ARG8 strain with 18 
or without the COA2 gene was radiolabeled as in Fig.5A. The bands corresponding to the 19 
Cox1::Arg8 fusion and to the mature Arg8 are marked.  D) Mitochondria (250 µg protein) 20 
isolated from either wild-type (WT), coa2∆ or pet309∆ strains containing a genomically 21 
tagged 13Myc MSS51 (MSS51::Myc) were solubilized in buffer containing 1.5% digitonin. 22 
Lysates were loaded onto a continuous 4-13% gradient gel and protein complexes were 23 
separated by BN-PAGE. The distribution of Mss51 complexes was analyzed by 24 
immunoblotting with anti-Myc antibody. E) coa2∆ yta12∆ cells transformed with a 25 
centromeric vector expressing Yta12 E614Q were grown in SC-2% raffinose, serially diluted 26 
and spotted on YP 2% glycerol-2% lactate (YPLG) or 2% glucose (YPD). The plates were 27 
incubated at 30°C for 2 days (YPD) or 6 days (YPLG).  28 
 29 
Fig. 7. Coa2 acts downstream of Coa1 and Shy1 in the assembly pathway of CcO. A)  30 
Cells were grown to mid-exponential phase and incubated with (+) or without (–) the 31 
 24 
indicated concentration of H2O2 for 2 h at 30 °C. Serial dilutions were spotted onto YPD 1 
plates and incubated for 36–48 h at 30 °C. B) Cells (W303 background) were treated like in 2 
A).  3 
 4 
Fig. 8. Overexpression of Cox5a can partially rescue the respiratory deficiency of coa2∆ 5 
cells. A) View of Cox1, Cox5a and Cox6 based on the structure of bovine CcO (37). Cox1 is 6 
shown in light gray, Cox5a and Cox6 are shown in black and dark gray, respectively. B) In 7 
vivo labeling of mitochondrial translation products in cells lacking CcO subunits. Cells 8 
(BY4743 background) were labeled for 8 and 20 min with [35S]-Met at 30°C. The samples 9 
were run on 12% SDS-PAGE, the gel was dried and exposed to autoradiographic film. C) 10 
W303 coa2∆ cells transformed with episomal vectors expressing COX5a or COX6 were 11 
grown in SC-2% raffinose, serially diluted and spotted on YP 2% glycerol-2% lactate (YPLG) 12 
or 2% glucose (YPD). The plates were incubated at 30°C and 37°C for 2 days (YPD) or 7 13 
days (YPLG). D) Immunoblot of TCA extracts from W303, coa2∆ and cox19∆ cells 14 
containing a centromeric vector expressing a 3HA C-terminal tagged version of COX5a under 15 
the control of its own promoter. Porin (Por1) is shown as a loading control. E) Mitochondria 16 
isolated from either wild-type (WT) or a strain containing a genomically tagged 13Myc COA2 17 
(COA2::Myc) were solubilized in buffer containing 1.5% digitonin. Lysates were separated 18 
by BN-PAGE (6-16% gradient gel) and analyzed as in Fig.6D. Monomeric (V1) and dimeric 19 
(V2) forms of respiratory chain complex V served as a control and were visualized using 20 
antisera against F1-subunit. 21 
 22 
Fig.9. Coa2 and Mss51 overexpression in cox5a∆ cells results in increased levels of Cox1. 23 
A) The COX1(1-512)::ARG8 strain lacking COX5a and with or without episomal vectors 24 
expressing COA2 or MSS51 were grown in SC-2% glucose containing 1x Arg (20 mg/L), 25 
serially diluted and spotted on SC-2% glucose containing 1x Arg (+Arg) or not (-Arg). The 26 
plates were incubated at 30°C for 2 days. B) W303 cox5a∆ cells containing the same plasmids 27 
as in A) were labeled for 8 and 20 min with [35S]-Met at 30°C. The samples were run on 12% 28 
SDS-PAGE, the gel was dried and exposed to autoradiographic film. C) The same cells as in 29 
B) were grown to midexponential phase and incubated with (+) or without (–) the indicated 30 
 25 
concentration of H2O2 for 2 h at 30 °C. Serial dilutions were spotted onto YPD plates and 1 
incubated for 36–48 h at 30 °C. 2 
 3 
Fig.10. Coa2 and Mss51 have a synergistic effect in enhancing respiration of coa1∆ and 4 
shy1∆ cells. A) BY4743 coa1∆ cells transformed with episomal vectors expressing MSS51, 5 
COA2 or both were grown in SC-2% raffinose, serially diluted and spotted on SC 2% 6 
glycerol-2% lactate (SCLG) or 2% glucose. The plates were incubated at 30°C for 2 days 7 
(glucose) or 6 days (SCLG). B) BY4743 shy1∆ cells transformed with the same vectors as in 8 
A) were grown in SC-2% raffinose, serially diluted and spotted on SC 2% glycerol-2% lactate 9 
(SCLG) or 2% glucose or YP 2% glycerol-2% lactate (YPLG). The plates were incubated at 10 
30°C for 2 days (glucose) or 6 days.  11 
 26 
Table I 1 
Yeast strains used in this study 2 
The strains with the 3 HA or 13Myc tags were generated in the DY5113 background by PCR-3 
based gene modification using the template pFA6a-3HA-TRP1, pFA6a-13MYC-TRP1, 4 
pFA6a-3HA-HIS3MX6 or pFA6a-13MYC-HIS3MX6 (24).  5 
Strain Genotype Reference/Source 
BY4741 MATa, his3∆1 leu2∆0 met15∆0 ura3∆0 Invitrogen Corp. 
BY4741 ∆coa2 MATa, his3∆1, leu2∆0, met15∆0 ura3∆0, ∆coa2:: kanMX4 This work 
W303  MATα ade2-1 his3-1,15 leu2-3,112 trp1-1, ura3-1  
W303 ∆coa2 MATα ade2-1 his3-1,15 leu2-3,112 trp1-1, ura3-1, ∆coa2:: kanMX4 This work 
W303 ∆coa2 ∆cox14 MATα ade2-1 his3-1,15 leu2-3,112 trp1-1, ura3-1, ∆coa2:: kanMX4, 
∆cox14:: Ca URA3 
This work 
W303 ∆coa2 MATα ade2-1 his3-1,15 leu2-3,112 trp1-1, ura3-1, ∆coa2:: Ca URA3 This work 
W303 ∆coa2 ∆yta12 MATα ade2-1 his3-1,15 leu2-3,112 trp1-1, ura3-1, ∆coa2:: Ca 
URA3, ∆yta12:: kanMX4 
This work 





MATα ade2-1 his3-1,15 leu2-3,112 trp1-1, ura3-1, ∆shy1::URA3 (7) 
W303 ∆shy1 ∆coa2 
 
MATα ade2-1 his3-1,15 leu2-3,112 trp1-1, ura3-1, ∆shy1::URA3, ∆coa2:: 
kanMX4 
This work 
W303 ∆cox5a MATα ade2-1 his3-1,15 leu2-3,112 trp1-1, ura3-1, ∆cox5a:: HIS3 (17) 
cox1∆::ARG8m MATa, lys2, leu2-3,112, arg8::hisG, ura3-52 [cox1∆::ARG8m] (30) 
cox1∆::ARG8m ∆coa2 MATa, lys2, leu2-3,112, arg8::hisG, ura3-52 [cox1∆::ARG8m], ∆coa2:: 
kanMX4 
This work 
COX1(1- 512)::ARG8 MATa, lys2, leu2-3,112, arg8::hisG, ura3-52,  [COX1(1- 512)::ARG8m] (30) 
COX1(1- 512)::ARG8 
∆coa2 





MATa, lys2, leu2-3,112, arg8::hisG, ura3-52,  [COX1(1- 512)::ARG8m], 
∆cox5a:: kanMX4 
This work 
DY5113  MATa ade2-1 his3-1,15 leu2-3,112 trp1∆, ura3-1 (21) 
COA2-3HA MATa ade2-1 his3-1,15 leu2-3,112 trp1∆, ura3-1, COA2-3HA::TRP1 This work 
COA2-13Myc MATa ade2-1 his3-1,15 leu2-3,112 trp1∆, ura3-1, COA2-13Myc::TRP1 This work 










MATa ade2-1 his3-1,15 leu2-3,112 trp1∆, ura3-1, COA1-3HA::TRP1, 




MATa ade2-1 his3-1,15 leu2-3,112 trp1∆, ura3-1, COA1-3HA::TRP1, 
MSS51-13Myc::HIS3MX6, ∆pet309:: CaURA3 
This work 
BY4743 ∆shy1 MATa/α his3∆1/his3∆1 leu2∆0/leu2∆0 LYS2/lys2∆0  MET15/met15∆0 
ura3∆0/ura3∆0 ∆shy1:: kanMX4 
Invitrogen Corp. 
BY4743 ∆coa1 MATa/α his3∆1/his3∆1 leu2∆0/leu2∆0 LYS2/lys2∆0  MET15/met15∆0 
ura3∆0/ura3∆0 ∆coa1:: kanMX4 
Invitrogen Corp. 
BY4743 MATa/α his3∆1/his3∆1 leu2∆0/leu2∆0 LYS2/lys2∆0  MET15/met15∆0 
ura3∆0/ura3∆0 
Invitrogen Corp. 
BY4743 ∆cox5a MATa/α his3∆1/his3∆1 leu2∆0/leu2∆0 LYS2/lys2∆0  MET15/met15∆0 
ura3∆0/ura3∆0, ∆cox5a:: kanMX4 
Invitrogen Corp. 
BY4743 ∆cox6 MATa/α his3∆1/his3∆1 leu2∆0/leu2∆0 LYS2/lys2∆0  MET15/met15∆0 
ura3∆0/ura3∆0, ∆cox6:: kanMX4 
Invitrogen Corp. 
BY4743 ∆cox7 MATa/α his3∆1/his3∆1 leu2∆0/leu2∆0 LYS2/lys2∆0  MET15/met15∆0 Invitrogen Corp. 
 27 
 1 
ura3∆0/ura3∆0, ∆cox7:: kanMX4 










